Semi-Quantitative [ 18 F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis

[18F]fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) is used to diagnose large vessel vasculitis in giant cell arteritis (GCA). We aimed to define a semi-quantitative threshold for identifying GCA aortitis from aortic atheroma or the control. Contrast enhanced c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2022-12, Vol.23 (24), p.15528
Hauptverfasser: Espitia, Olivier, Schanus, Jérémy, Agard, Christian, Kraeber-Bodéré, Françoise, Guédon, Alexis F, Bénichou, Antoine, Serfaty, Jean-Michel, Coudol, Sandrine, Karakachoff, Matilde, Jamet, Bastien
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 24
container_start_page 15528
container_title International journal of molecular sciences
container_volume 23
creator Espitia, Olivier
Schanus, Jérémy
Agard, Christian
Kraeber-Bodéré, Françoise
Guédon, Alexis F
Bénichou, Antoine
Serfaty, Jean-Michel
Coudol, Sandrine
Karakachoff, Matilde
Jamet, Bastien
description [18F]fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) is used to diagnose large vessel vasculitis in giant cell arteritis (GCA). We aimed to define a semi-quantitative threshold for identifying GCA aortitis from aortic atheroma or the control. Contrast enhanced computed tomography (CECT) was used as the reference imaging for aortic evaluation and to define aortitis, aortic atheroma and control aortas. [18F]FDG-PET/CT was performed on 35 GCA patients and in two different control groups (aortic atheroma (n = 70) and normal control (n = 35)). Aortic semi-quantitative features were compared between the three groups. GCA patients without aortitis on CECT were excluded. Of the GCA patients, 19 (54.3%) were not on glucocorticoids (GC) prior to [18F]FDG-PET/CT. The SUVmax, TBRblood and TBRliver aortic values were significantly higher in the GCA aortitis group than in the aortic atheroma and control groups (p < 0.001). Receiver operating characteristic curve analyses brought to light quantitative cut-off values allowing GCA aortitis diagnosis with optimal sensitivity and specificity versus control or aortic atheroma patients for each PET-based feature analyzed. Considering the overall aorta, a SUVmax threshold of 3.25 and a TBRblood threshold of 1.75 had a specificity of 83% and 75%, respectively, a sensitivity of 81% and 81%, respectively, and the area under the ROC curve (AUC) was 0.86 and 0.83, respectively, for aortitis detection compared to control groups in GCA cases with GC. A SUVmax threshold of 3.45 and a TBRblood threshold of 1.97 had a specificity of 90% and 93%, respectively, a sensitivity of 89% and 89%, respectively, with an AUC of 0.89 and 0.96, respectively, for aortitis detection compared to the control in GC-free GCA cases. Discriminative thresholds of SUVmax and TBRblood for the diagnosis of GCA aortitis were established using CECT as the reference imaging.
doi_str_mv 10.3390/ijms232415528
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9779846</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2758100934</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-447a27625c29a7ef62beebcfde521f98f4a2900f354c910faf66662e855016a3</originalsourceid><addsrcrecordid>eNpdkU1vEzEQhi1ERUvhyBVZ4gIHU397fUFatk1aKVL4yA0hy9nY1NHuurV3I_Xf45BStfVlRp5n3vH4BeAdwZ8Z0_gsbPtMGeVECFq9ACeEU4owlurlo_wYvM55i3EBhX4FjpkUQhCpT0D86fqAvk92GMNox7Bz8BckFZz9np3P0beL1Vmzgj-WDaoH293lkNFXm90GNtOIlt5n6GOCdUylO2R47nwYShYHGAY4D0UVNq7rYJ1Gl_bIG3DkbZfd2_t4Clazi1VziRbL-VVTL1DLsRgR58pSJaloqbbKeUnXzq1bv3GCEq8rzy3VGHsmeKsJ9tbLcqirhMBEWnYKvhxkb6Z17zatG8ZkO3OTQm_TnYk2mKeVIVybP3FntFK64rIIfDoIXD9ru6wXZn-HueKMErkjhf14PyzF28nl0fQht2VtO7g4ZUOVqAjGmvGCfniGbuOUytf-o6RimuI9hQ5Um2LOyfmHFxBs9q6bJ64X_v3jbR_o_zazvzWYph0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2756739204</pqid></control><display><type>article</type><title>Semi-Quantitative [ 18 F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Espitia, Olivier ; Schanus, Jérémy ; Agard, Christian ; Kraeber-Bodéré, Françoise ; Guédon, Alexis F ; Bénichou, Antoine ; Serfaty, Jean-Michel ; Coudol, Sandrine ; Karakachoff, Matilde ; Jamet, Bastien</creator><creatorcontrib>Espitia, Olivier ; Schanus, Jérémy ; Agard, Christian ; Kraeber-Bodéré, Françoise ; Guédon, Alexis F ; Bénichou, Antoine ; Serfaty, Jean-Michel ; Coudol, Sandrine ; Karakachoff, Matilde ; Jamet, Bastien</creatorcontrib><description>[18F]fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) is used to diagnose large vessel vasculitis in giant cell arteritis (GCA). We aimed to define a semi-quantitative threshold for identifying GCA aortitis from aortic atheroma or the control. Contrast enhanced computed tomography (CECT) was used as the reference imaging for aortic evaluation and to define aortitis, aortic atheroma and control aortas. [18F]FDG-PET/CT was performed on 35 GCA patients and in two different control groups (aortic atheroma (n = 70) and normal control (n = 35)). Aortic semi-quantitative features were compared between the three groups. GCA patients without aortitis on CECT were excluded. Of the GCA patients, 19 (54.3%) were not on glucocorticoids (GC) prior to [18F]FDG-PET/CT. The SUVmax, TBRblood and TBRliver aortic values were significantly higher in the GCA aortitis group than in the aortic atheroma and control groups (p &lt; 0.001). Receiver operating characteristic curve analyses brought to light quantitative cut-off values allowing GCA aortitis diagnosis with optimal sensitivity and specificity versus control or aortic atheroma patients for each PET-based feature analyzed. Considering the overall aorta, a SUVmax threshold of 3.25 and a TBRblood threshold of 1.75 had a specificity of 83% and 75%, respectively, a sensitivity of 81% and 81%, respectively, and the area under the ROC curve (AUC) was 0.86 and 0.83, respectively, for aortitis detection compared to control groups in GCA cases with GC. A SUVmax threshold of 3.45 and a TBRblood threshold of 1.97 had a specificity of 90% and 93%, respectively, a sensitivity of 89% and 89%, respectively, with an AUC of 0.89 and 0.96, respectively, for aortitis detection compared to the control in GC-free GCA cases. Discriminative thresholds of SUVmax and TBRblood for the diagnosis of GCA aortitis were established using CECT as the reference imaging.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms232415528</identifier><identifier>PMID: 36555169</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Aorta ; Aortitis ; Aortitis - diagnostic imaging ; Arteritis ; Biopsy ; Computed tomography ; Diagnosis ; Fluorine isotopes ; Fluorodeoxyglucose F18 ; Giant Cell Arteritis ; Giant Cell Arteritis - diagnostic imaging ; Glucocorticoids ; Humans ; Life Sciences ; Liver ; Medical imaging ; Plaque, Atherosclerotic ; Positron emission ; Positron emission tomography ; Positron Emission Tomography Computed Tomography ; Positron Emission Tomography Computed Tomography - methods ; Quantitative analysis ; Radiopharmaceuticals ; Reproducibility ; Retrospective Studies ; ROC Curve ; Sensitivity ; Steroids ; Tomography ; Vasculitis ; Vein &amp; artery diseases</subject><ispartof>International journal of molecular sciences, 2022-12, Vol.23 (24), p.15528</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Attribution</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c405t-447a27625c29a7ef62beebcfde521f98f4a2900f354c910faf66662e855016a3</cites><orcidid>0000-0003-0821-9990 ; 0000-0002-1156-0607 ; 0000-0002-2145-9182 ; 0000-0001-8801-1414</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779846/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779846/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36555169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04743216$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Espitia, Olivier</creatorcontrib><creatorcontrib>Schanus, Jérémy</creatorcontrib><creatorcontrib>Agard, Christian</creatorcontrib><creatorcontrib>Kraeber-Bodéré, Françoise</creatorcontrib><creatorcontrib>Guédon, Alexis F</creatorcontrib><creatorcontrib>Bénichou, Antoine</creatorcontrib><creatorcontrib>Serfaty, Jean-Michel</creatorcontrib><creatorcontrib>Coudol, Sandrine</creatorcontrib><creatorcontrib>Karakachoff, Matilde</creatorcontrib><creatorcontrib>Jamet, Bastien</creatorcontrib><title>Semi-Quantitative [ 18 F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>[18F]fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) is used to diagnose large vessel vasculitis in giant cell arteritis (GCA). We aimed to define a semi-quantitative threshold for identifying GCA aortitis from aortic atheroma or the control. Contrast enhanced computed tomography (CECT) was used as the reference imaging for aortic evaluation and to define aortitis, aortic atheroma and control aortas. [18F]FDG-PET/CT was performed on 35 GCA patients and in two different control groups (aortic atheroma (n = 70) and normal control (n = 35)). Aortic semi-quantitative features were compared between the three groups. GCA patients without aortitis on CECT were excluded. Of the GCA patients, 19 (54.3%) were not on glucocorticoids (GC) prior to [18F]FDG-PET/CT. The SUVmax, TBRblood and TBRliver aortic values were significantly higher in the GCA aortitis group than in the aortic atheroma and control groups (p &lt; 0.001). Receiver operating characteristic curve analyses brought to light quantitative cut-off values allowing GCA aortitis diagnosis with optimal sensitivity and specificity versus control or aortic atheroma patients for each PET-based feature analyzed. Considering the overall aorta, a SUVmax threshold of 3.25 and a TBRblood threshold of 1.75 had a specificity of 83% and 75%, respectively, a sensitivity of 81% and 81%, respectively, and the area under the ROC curve (AUC) was 0.86 and 0.83, respectively, for aortitis detection compared to control groups in GCA cases with GC. A SUVmax threshold of 3.45 and a TBRblood threshold of 1.97 had a specificity of 90% and 93%, respectively, a sensitivity of 89% and 89%, respectively, with an AUC of 0.89 and 0.96, respectively, for aortitis detection compared to the control in GC-free GCA cases. Discriminative thresholds of SUVmax and TBRblood for the diagnosis of GCA aortitis were established using CECT as the reference imaging.</description><subject>Aorta</subject><subject>Aortitis</subject><subject>Aortitis - diagnostic imaging</subject><subject>Arteritis</subject><subject>Biopsy</subject><subject>Computed tomography</subject><subject>Diagnosis</subject><subject>Fluorine isotopes</subject><subject>Fluorodeoxyglucose F18</subject><subject>Giant Cell Arteritis</subject><subject>Giant Cell Arteritis - diagnostic imaging</subject><subject>Glucocorticoids</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Liver</subject><subject>Medical imaging</subject><subject>Plaque, Atherosclerotic</subject><subject>Positron emission</subject><subject>Positron emission tomography</subject><subject>Positron Emission Tomography Computed Tomography</subject><subject>Positron Emission Tomography Computed Tomography - methods</subject><subject>Quantitative analysis</subject><subject>Radiopharmaceuticals</subject><subject>Reproducibility</subject><subject>Retrospective Studies</subject><subject>ROC Curve</subject><subject>Sensitivity</subject><subject>Steroids</subject><subject>Tomography</subject><subject>Vasculitis</subject><subject>Vein &amp; artery diseases</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkU1vEzEQhi1ERUvhyBVZ4gIHU397fUFatk1aKVL4yA0hy9nY1NHuurV3I_Xf45BStfVlRp5n3vH4BeAdwZ8Z0_gsbPtMGeVECFq9ACeEU4owlurlo_wYvM55i3EBhX4FjpkUQhCpT0D86fqAvk92GMNox7Bz8BckFZz9np3P0beL1Vmzgj-WDaoH293lkNFXm90GNtOIlt5n6GOCdUylO2R47nwYShYHGAY4D0UVNq7rYJ1Gl_bIG3DkbZfd2_t4Clazi1VziRbL-VVTL1DLsRgR58pSJaloqbbKeUnXzq1bv3GCEq8rzy3VGHsmeKsJ9tbLcqirhMBEWnYKvhxkb6Z17zatG8ZkO3OTQm_TnYk2mKeVIVybP3FntFK64rIIfDoIXD9ru6wXZn-HueKMErkjhf14PyzF28nl0fQht2VtO7g4ZUOVqAjGmvGCfniGbuOUytf-o6RimuI9hQ5Um2LOyfmHFxBs9q6bJ64X_v3jbR_o_zazvzWYph0</recordid><startdate>20221208</startdate><enddate>20221208</enddate><creator>Espitia, Olivier</creator><creator>Schanus, Jérémy</creator><creator>Agard, Christian</creator><creator>Kraeber-Bodéré, Françoise</creator><creator>Guédon, Alexis F</creator><creator>Bénichou, Antoine</creator><creator>Serfaty, Jean-Michel</creator><creator>Coudol, Sandrine</creator><creator>Karakachoff, Matilde</creator><creator>Jamet, Bastien</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0821-9990</orcidid><orcidid>https://orcid.org/0000-0002-1156-0607</orcidid><orcidid>https://orcid.org/0000-0002-2145-9182</orcidid><orcidid>https://orcid.org/0000-0001-8801-1414</orcidid></search><sort><creationdate>20221208</creationdate><title>Semi-Quantitative [ 18 F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis</title><author>Espitia, Olivier ; Schanus, Jérémy ; Agard, Christian ; Kraeber-Bodéré, Françoise ; Guédon, Alexis F ; Bénichou, Antoine ; Serfaty, Jean-Michel ; Coudol, Sandrine ; Karakachoff, Matilde ; Jamet, Bastien</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-447a27625c29a7ef62beebcfde521f98f4a2900f354c910faf66662e855016a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aorta</topic><topic>Aortitis</topic><topic>Aortitis - diagnostic imaging</topic><topic>Arteritis</topic><topic>Biopsy</topic><topic>Computed tomography</topic><topic>Diagnosis</topic><topic>Fluorine isotopes</topic><topic>Fluorodeoxyglucose F18</topic><topic>Giant Cell Arteritis</topic><topic>Giant Cell Arteritis - diagnostic imaging</topic><topic>Glucocorticoids</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Liver</topic><topic>Medical imaging</topic><topic>Plaque, Atherosclerotic</topic><topic>Positron emission</topic><topic>Positron emission tomography</topic><topic>Positron Emission Tomography Computed Tomography</topic><topic>Positron Emission Tomography Computed Tomography - methods</topic><topic>Quantitative analysis</topic><topic>Radiopharmaceuticals</topic><topic>Reproducibility</topic><topic>Retrospective Studies</topic><topic>ROC Curve</topic><topic>Sensitivity</topic><topic>Steroids</topic><topic>Tomography</topic><topic>Vasculitis</topic><topic>Vein &amp; artery diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Espitia, Olivier</creatorcontrib><creatorcontrib>Schanus, Jérémy</creatorcontrib><creatorcontrib>Agard, Christian</creatorcontrib><creatorcontrib>Kraeber-Bodéré, Françoise</creatorcontrib><creatorcontrib>Guédon, Alexis F</creatorcontrib><creatorcontrib>Bénichou, Antoine</creatorcontrib><creatorcontrib>Serfaty, Jean-Michel</creatorcontrib><creatorcontrib>Coudol, Sandrine</creatorcontrib><creatorcontrib>Karakachoff, Matilde</creatorcontrib><creatorcontrib>Jamet, Bastien</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Espitia, Olivier</au><au>Schanus, Jérémy</au><au>Agard, Christian</au><au>Kraeber-Bodéré, Françoise</au><au>Guédon, Alexis F</au><au>Bénichou, Antoine</au><au>Serfaty, Jean-Michel</au><au>Coudol, Sandrine</au><au>Karakachoff, Matilde</au><au>Jamet, Bastien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Semi-Quantitative [ 18 F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2022-12-08</date><risdate>2022</risdate><volume>23</volume><issue>24</issue><spage>15528</spage><pages>15528-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>[18F]fluorodeoxyglucose-positron emission tomography/computed tomography ([18F]FDG-PET/CT) is used to diagnose large vessel vasculitis in giant cell arteritis (GCA). We aimed to define a semi-quantitative threshold for identifying GCA aortitis from aortic atheroma or the control. Contrast enhanced computed tomography (CECT) was used as the reference imaging for aortic evaluation and to define aortitis, aortic atheroma and control aortas. [18F]FDG-PET/CT was performed on 35 GCA patients and in two different control groups (aortic atheroma (n = 70) and normal control (n = 35)). Aortic semi-quantitative features were compared between the three groups. GCA patients without aortitis on CECT were excluded. Of the GCA patients, 19 (54.3%) were not on glucocorticoids (GC) prior to [18F]FDG-PET/CT. The SUVmax, TBRblood and TBRliver aortic values were significantly higher in the GCA aortitis group than in the aortic atheroma and control groups (p &lt; 0.001). Receiver operating characteristic curve analyses brought to light quantitative cut-off values allowing GCA aortitis diagnosis with optimal sensitivity and specificity versus control or aortic atheroma patients for each PET-based feature analyzed. Considering the overall aorta, a SUVmax threshold of 3.25 and a TBRblood threshold of 1.75 had a specificity of 83% and 75%, respectively, a sensitivity of 81% and 81%, respectively, and the area under the ROC curve (AUC) was 0.86 and 0.83, respectively, for aortitis detection compared to control groups in GCA cases with GC. A SUVmax threshold of 3.45 and a TBRblood threshold of 1.97 had a specificity of 90% and 93%, respectively, a sensitivity of 89% and 89%, respectively, with an AUC of 0.89 and 0.96, respectively, for aortitis detection compared to the control in GC-free GCA cases. Discriminative thresholds of SUVmax and TBRblood for the diagnosis of GCA aortitis were established using CECT as the reference imaging.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36555169</pmid><doi>10.3390/ijms232415528</doi><orcidid>https://orcid.org/0000-0003-0821-9990</orcidid><orcidid>https://orcid.org/0000-0002-1156-0607</orcidid><orcidid>https://orcid.org/0000-0002-2145-9182</orcidid><orcidid>https://orcid.org/0000-0001-8801-1414</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2022-12, Vol.23 (24), p.15528
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9779846
source MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Aorta
Aortitis
Aortitis - diagnostic imaging
Arteritis
Biopsy
Computed tomography
Diagnosis
Fluorine isotopes
Fluorodeoxyglucose F18
Giant Cell Arteritis
Giant Cell Arteritis - diagnostic imaging
Glucocorticoids
Humans
Life Sciences
Liver
Medical imaging
Plaque, Atherosclerotic
Positron emission
Positron emission tomography
Positron Emission Tomography Computed Tomography
Positron Emission Tomography Computed Tomography - methods
Quantitative analysis
Radiopharmaceuticals
Reproducibility
Retrospective Studies
ROC Curve
Sensitivity
Steroids
Tomography
Vasculitis
Vein & artery diseases
title Semi-Quantitative [ 18 F]FDG-PET/CT ROC-Analysis-Based Cut-Offs for Aortitis Definition in Giant Cell Arteritis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T07%3A43%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Semi-Quantitative%20%5B%2018%20F%5DFDG-PET/CT%20ROC-Analysis-Based%20Cut-Offs%20for%20Aortitis%20Definition%20in%20Giant%20Cell%20Arteritis&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Espitia,%20Olivier&rft.date=2022-12-08&rft.volume=23&rft.issue=24&rft.spage=15528&rft.pages=15528-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms232415528&rft_dat=%3Cproquest_pubme%3E2758100934%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2756739204&rft_id=info:pmid/36555169&rfr_iscdi=true